Gerardo Rosati

Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial

C. Aschele, L. Cionini, Sara Lonardi et al. · Journal of Clinical Oncology · 2011 · 764 citations · Full text

Medicine, Oncology, Surgery +17

A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma

Gerardo Rosati, G. Ambrosini, Sandro Barni et al. · Annals of Oncology · 2015 · 134 citations · Full text

Medicine, Oncology, Surgery +12

Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial

C. Aschele, Carmine Pinto, Stefano Cordio et al. · Journal of Clinical Oncology · 2009 · 106 citations

Medicine, Oncology, Surgery +17

Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer

Timothy Iveson, Alberto Sobrero, Takayuki Yoshino et al. · Journal of Clinical Oncology · 2021 · 104 citations · Full text

Medicine, Pharmacology, Chemotherapy +7

Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma

Fabio Calabrò, Vito Lorusso, Gerardo Rosati et al. · Cancer · 2009 · 92 citations · Full text

Medicine, Oncology, Pharmacology +14